Demand for nephrology and urology devices is rising across India, driven by the growing need for kidney disease diagnosis, monitoring, and accessible healthcare technologies. Against this backdrop, India’s nephrology and urology devices market is projected to grow at a compound annual growth rate (CAGR) of 7% between 2025 and 2035, according to GlobalData, a leading intelligence and productivity platform.

GlobalData research highlights that India accounted for around 10% of the Asia-Pacific (APAC) nephrology and urology devices market in 2025, influenced by factors such as the elevated prevalence of renal and urinary disorders.

In July 2026, researchers at BITS Pilani, Hyderabad, developed a portable, internet-enabled diagnostic device that can simultaneously detect three key kidney-related biomarkers–uric acid, urea, and creatinine from a small blood serum sample. The device processes the sample using a compact sensing chip and wirelessly transmits the results, which can be accessed through a smartphone, tablet, or computer, enabling rapid assessment of kidney function.

Nidhi Bharti, Medical Devices Analyst at GlobalData, comments: “India continues to face challenges in ensuring timely assessment of kidney health as the burden of renal disorders increases. Chronic kidney disease (CKD) is largely asymptomatic in its early stages, so many patients in India reach a nephrologist only after an irreversible loss of kidney function. The emergence of compact, internet-enabled diagnostic technologies could enable faster, multi-parameter assessment, potentially reducing reliance on conventional laboratory-based testing and improving access to diagnostic services across nephrology and urology care.”

Investment in AI-enabled and point-of-care diagnostic technologies is expected to gain momentum as healthcare providers seek early detection, particularly in rural and remote areas where access to healthcare facilities remains limited. Rising demand and growing burden of CKD, combined with limited awareness, highlight the need for accessible screening and early diagnosis.

Bharti concludes: “As demand for kidney disease diagnosis and monitoring increases, innovation in connected diagnostic technologies is expected to support more efficient and timely renal health assessment. This growing need, coupled with the potential to improve early detection and disease monitoring, is likely to attract greater investment over the next decade. Continued development and adoption of such devices are expected to contribute to the long-term growth of India’s nephrology and urology devices market.”